Time filter

Source Type

Olar R.,University of Bucharest | Vlaicu I.D.,University of Bucharest | Vlaicu I.D.,National Institute of Materials Physics Bucharest | Chifiriuc M.C.,University of Bucharest | And 6 more authors.
Journal of Thermal Analysis and Calorimetry | Year: 2016

Synthesis and characterization of four new Ni(II) complexes with mixed ligands have been reported in the present paper. As interest ligands, acrylate (acr) ion together with one N-donor heterocyclic ligand, namely benzimidazole (HBzIm), 2-methylbenzimidazole (2-MeBzIm), 5-methylbenzimidazole (5-MeBzIm) or 5,6-dimethylbenzimidazole (5,6-Me2BzIm), was chosen. The syntheses afforded the complexes formulated as [Ni(HBzIm)2(acr)2(H2O)]·3H2O (1), [Ni(2-MeBzIm)2(acr)2(H2O)]·1.5H2O (2), [Ni(5-MeBzIm)2(acr)2(H2O)] (3) and [Ni(5,6-Me2BzIm)2(acr)2] (4). Complexes (1) and (2) contain crystallization water molecules and coordinated water molecules, both their nature and presence being confirmed on the basis of IR spectra and thermal analysis. In contrast to above-mentioned complexes, (3) contains only coordinated water molecule, while (4) is an anhydrous compound. Based on electronic spectra and magnetic measurements, a distorted octahedral stereochemistry was proposed for all Ni(II) complexes. Acrylate ions act both as unidentate and chelate ligands in complexes (1)–(3), while in complex (4) act only as chelate ligands. All used N-donor ligands function as monodentate in all Ni(II) complexes. Biological properties of complexes (1)–(4) were evaluated against several Gram(+), Gram(−) bacterial strains and against fungus Candida albicans. © 2016 Akadémiai Kiadó, Budapest, Hungary

Silvestro L.,3S Pharmacological Consultation and Research GmbH | Gheorghe M.,Pharma Serv Intl SRL | Gheorghe M.,University of Bucharest | Iordachescu A.,Pharma Serv Intl SRL | And 4 more authors.
Analytical and Bioanalytical Chemistry | Year: 2011

A new sensitive and fast quantitative analytical method for the simultaneous determination of clopidogrel, its main metabolite clopidogrel carboxylic acid, and the newly described acyl glucuronide metabolite, in human plasma samples, is presented. The analytical procedures (plasma storage, handling, and extract storage in the autosampler) were optimized in order to avoid back-conversion; a known drawback in measurements of clopidogrel. Clopidogrel acyl glucuronide was confirmed as a major source of back-conversion to the parent drug in the presence of methanol, and thorough stability experiments were carried out to find the most appropriate conditions for an accurate analysis of clopidogrel and the two metabolites. The method was validated by assessing selectivity, sensitivity, linearity, accuracy, and precision for all three analytes, in accordance to Food and Drug Administration guidelines. Spiked quality controls in plasma as well as incurred samples were used to verify back-conversion in the selected conditions, with results meeting European Medicines Agency acceptance criteria (concentrations within 80-120% of the first reading). The method was then applied to a pharmacokinetic study, and for the first time, a pharmacokinetic curve of clopidogrel acyl glucuronide in human plasma is presented. The concentrations ranged up to 1,048.684 ng/mL, with a mean of 470.268 ng/mL, while clopidogrel had a mean C max of 1.348 ng/mL; these orders of magnitude show how much the back-conversion of this metabolite may influence clopidogrel quantification if it is not properly controlled. © 2011 Springer-Verlag.

Iordachescu A.,Pharma Serv Intl SRL | Iordachescu A.,University of Bucharest | Silvestro L.,3S Pharmacological Consultation and Research GmbH | Tudoroniu A.,Pharma Serv Intl SRL | And 2 more authors.
Chromatographia | Year: 2012

This paper presents a new analytical method with adequate sensitivity, precision, accuracy, and specificity to quantitatively determine (-)-donepezil and (+)-donepezil in plasma, at concentrations that can be expected in real samples of pharmacokinetic studies. This method combines a HPLC separation on cellulose tris (3,5-dimethylphenyl carbamate) coated on 5-lm silica-gel column known as CHIRALCEL OD-RH eluted with mobile phase consisting of acetonitrile and ammonium bicarbonate and MS-MS detection. Under the HPLC conditions used (-)-donepezil and (+)-donepezil, as well as the enantiomers of the internal standard d 7-donepezil, eluted at 5 and 6.25 min, respectively. The curve fittings were optimal for the entire calibration range (0.05-25.0 ng mL -1) with correlation coefficients (r) = 0.999 for (-)-donepezil and (r) = 0.999 for (+)-donepezil (linear regression model with 1/x 2 weighing). The assay method showed a good specificity for donepezil enantiomers, and it could be successfully applied to pharmacokinetic studies. © Springer-Verlag 2012.

Silvestro L.,3S Pharmacological Consultation and Research GmbH | Savu S.R.,3S Pharmacological Consultation and Research GmbH | Savu S.N.,Pharma Serv Intl SRL | Tudoroniu A.,Pharma Serv Intl SRL | Tarcomnicu I.,Pharma Serv Intl SRL
Biomedical Chromatography | Year: 2012

A new method for the fast simultaneous quantification of fluticasone propionate and salmeterol from plasma samples by liquid chromatography-tandem mass spectrometry, with adequate sensitivity for pharmacokinetic applications, was developed and validated. The chromatographic separation and mass-spectrometric parameters were optimized for the retention and detection of the two compounds, despite quite different structures and properties. Two columns connected in series were used, cation-exchange (Zorbax 300-SCX, 5cm×2.1mm, 5μm) and octadecyl (Discovery HSC 18, 10cm×2.1mm, 5μm). The mass-spectrometric interface was operated in negative electrospray ionization mode; high sensitivity and lesser matrix effects were obtained, permitting smaller consumption of plasma. The sample preparation was based on supported liquid-liquid extraction in 96-well format plates that provided clean samples with a simplified procedure that was suitable for automation. The method was validated according to regulatory guidelines, by assessing lower limits of quantification, selectivity, linearity, accuracy, precision, extraction recoveries and matrix effects. A comparison with two other methods for the separate determination of fluticasone propionate and salmeterol in plasma samples, previously developed by our group, is presented. The statistical evaluation of the results obtained with the three methods on a set of unknown samples from treated patients demonstrated good correlation (R 2 0.987 for fluticasone propionate and 0.967 for salmeterol). © 2011 John Wiley & Sons, Ltd.

Silvestro L.,3S Pharmacological Consultation and Research GmbH | Savu S.R.,3S Pharmacological Consultation and Research GmbH
Bioanalysis | Year: 2015

Solid phase-supported liquid extraction (SLE) is a technique almost 40 years old being rediscovered in the last few years due to its simplicity, optimal for automation and giving very clean extracts with minimal matrix effects when analyzed by techniques like HPLC-MS/MS, GC-MS/MS, CE-MS/MS. In the next paragraphs the evolution of SLE, according to literature, will be presented first, followed by some considerations on the SLE material now available and a typical protocol of work. To conclude, considerations based on the author's practical experiences with SLE will be done, as well as few remarks on potential future areas of SLE development. © 2015 Future Science Ltd.

Discover hidden collaborations